Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Operating Expenses | 1,436 | 0 | 951 | 1,371 | 1,336 |
| Operating Income | -1,436 | N/A | -951 | -1,371 | -1,336 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 30 |
| Pre-tax Income | -1,437 | 0 | -951 | -1,370 | -1,306 |
| Net Income Continuous | -1,437 | N/A | -951 | -1,370 | -1,306 |
| Net Income | $-1,437 | $N/A | $-951 | $-1,370 | $-1,306 |
| EPS Basic Total Ops | -37.78 | N/A | -72.86 | -107.94 | -105.24 |
| EPS Basic Continuous Ops | -37.95 | N/A | -74.04 | -107.92 | -104.86 |
| EPS Diluted Total Ops | -37.78 | N/A | -72.86 | -107.94 | -105.24 |
| EPS Diluted Continuous Ops | -37.95 | N/A | -74.04 | -107.92 | -104.86 |
| EBITDA(a) | $-1,436 | $N/A | $-951 | $-1,370 | $-1,336 |